ATE532526T1 - Zelltherapie: verfahren und zusammensetzung zur behandlung von diabetes - Google Patents
Zelltherapie: verfahren und zusammensetzung zur behandlung von diabetesInfo
- Publication number
- ATE532526T1 ATE532526T1 AT07760776T AT07760776T ATE532526T1 AT E532526 T1 ATE532526 T1 AT E532526T1 AT 07760776 T AT07760776 T AT 07760776T AT 07760776 T AT07760776 T AT 07760776T AT E532526 T1 ATE532526 T1 AT E532526T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- cell therapy
- treating diabetes
- pancreases
- islet cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Developmental Biology & Embryology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79292906P | 2006-04-17 | 2006-04-17 | |
PCT/US2007/066786 WO2007121438A2 (en) | 2006-04-17 | 2007-04-17 | Cell therapy: a method and a composition for treating diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE532526T1 true ATE532526T1 (de) | 2011-11-15 |
Family
ID=38610440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07760776T ATE532526T1 (de) | 2006-04-17 | 2007-04-17 | Zelltherapie: verfahren und zusammensetzung zur behandlung von diabetes |
Country Status (15)
Country | Link |
---|---|
US (2) | US9574180B2 (de) |
EP (1) | EP2013332B1 (de) |
AT (1) | ATE532526T1 (de) |
AU (1) | AU2007237934B2 (de) |
CA (1) | CA2649706C (de) |
CY (1) | CY1112307T1 (de) |
ES (1) | ES2377464T3 (de) |
HK (1) | HK1127086A1 (de) |
IL (1) | IL194796A (de) |
NZ (1) | NZ572839A (de) |
PL (1) | PL2013332T3 (de) |
PT (1) | PT2013332E (de) |
RU (1) | RU2450052C2 (de) |
WO (1) | WO2007121438A2 (de) |
ZA (1) | ZA200809767B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014151229A1 (en) * | 2013-03-15 | 2014-09-25 | Philadelphia Medical Scientific Center, L.L.C. | Cell therapy: a method and a composition for treating diabetes |
RU2534911C1 (ru) * | 2013-10-29 | 2014-12-10 | Сергей Михайлович Чудных | Способ лечения сахарного диабета в эксперименте |
US20200224165A1 (en) * | 2016-07-22 | 2020-07-16 | Senlin Li | Methods and compositions for rejuvenation |
US11617832B2 (en) | 2016-08-17 | 2023-04-04 | International Business Machines Corporation | Portal system-based bionic pancreas |
KR102060609B1 (ko) | 2018-09-13 | 2019-12-30 | 사회복지법인 삼성생명공익재단 | 유도만능줄기세포 유래 내피세포와 요독 복합체를 사용한 요독성 혈관병증 모델 및 이의 이용 |
WO2023227068A1 (en) * | 2022-05-25 | 2023-11-30 | Hangzhou Reprogenix Bioscience, Inc. | A new site for transplantation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2069563C1 (ru) * | 1993-03-04 | 1996-11-27 | Шилкин Герман Алексеевич | Способ лечения диабетической ретинопатии |
US5741334A (en) * | 1995-06-07 | 1998-04-21 | Circe Biomedical, Inc. | Artificial pancreatic perfusion device |
RU2135193C1 (ru) * | 1997-10-28 | 1999-08-27 | Скалецкий Николай Николаевич | Способ получения материала, содержащего бета-клетки поджелудочной железы, для трансплантации больным сахарным диабетом с использованием феномена миграции клеток, материал, содержащий бета-клетки поджелудочной железы, для трансплантации больным сахарным диабетом и способ лечения сахарного диабета методом его трансплантации |
US20020071824A1 (en) * | 1999-05-27 | 2002-06-13 | Nick Giannoukakis | Gene transfer to pancreatic b cells for prevention of islet dysfunction |
EP1317253A4 (de) * | 2000-07-28 | 2006-04-26 | Univ Emory | Biologische komponente eine künstliche membran enthaltend |
US8236771B2 (en) * | 2004-05-18 | 2012-08-07 | National Institute Of Transplantation Foundation | Vectors and methods for long-term immune evasion to prolong transplant viability |
-
2007
- 2007-04-17 PT PT07760776T patent/PT2013332E/pt unknown
- 2007-04-17 ES ES07760776T patent/ES2377464T3/es active Active
- 2007-04-17 CA CA2649706A patent/CA2649706C/en active Active
- 2007-04-17 PL PL07760776T patent/PL2013332T3/pl unknown
- 2007-04-17 AT AT07760776T patent/ATE532526T1/de active
- 2007-04-17 EP EP07760776A patent/EP2013332B1/de active Active
- 2007-04-17 RU RU2008145053/10A patent/RU2450052C2/ru active
- 2007-04-17 NZ NZ572839A patent/NZ572839A/en not_active IP Right Cessation
- 2007-04-17 WO PCT/US2007/066786 patent/WO2007121438A2/en active Application Filing
- 2007-04-17 AU AU2007237934A patent/AU2007237934B2/en not_active Ceased
- 2007-04-17 US US12/094,721 patent/US9574180B2/en active Active
-
2008
- 2008-10-22 IL IL194796A patent/IL194796A/en active IP Right Grant
- 2008-11-17 ZA ZA200809767A patent/ZA200809767B/xx unknown
-
2009
- 2009-07-14 HK HK09106312.9A patent/HK1127086A1/xx unknown
-
2012
- 2012-02-07 CY CY20121100129T patent/CY1112307T1/el unknown
-
2015
- 2015-04-24 US US14/695,602 patent/US20150284687A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US9574180B2 (en) | 2017-02-21 |
RU2008145053A (ru) | 2010-05-27 |
PL2013332T3 (pl) | 2012-04-30 |
WO2007121438A3 (en) | 2008-03-27 |
PT2013332E (pt) | 2012-02-20 |
AU2007237934A1 (en) | 2007-10-25 |
CY1112307T1 (el) | 2015-12-09 |
ES2377464T3 (es) | 2012-03-27 |
US20150284687A1 (en) | 2015-10-08 |
RU2450052C2 (ru) | 2012-05-10 |
IL194796A0 (en) | 2009-08-03 |
NZ572839A (en) | 2011-12-22 |
US20080267925A1 (en) | 2008-10-30 |
WO2007121438A2 (en) | 2007-10-25 |
IL194796A (en) | 2014-02-27 |
EP2013332B1 (de) | 2011-11-09 |
CA2649706C (en) | 2013-06-11 |
EP2013332A2 (de) | 2009-01-14 |
ZA200809767B (en) | 2009-11-25 |
AU2007237934B2 (en) | 2012-11-01 |
EP2013332A4 (de) | 2009-05-13 |
HK1127086A1 (en) | 2009-09-18 |
CA2649706A1 (en) | 2007-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE532526T1 (de) | Zelltherapie: verfahren und zusammensetzung zur behandlung von diabetes | |
ATE523585T1 (de) | Differenzierung menschlicher embryonaler stammzellen | |
RU2012105922A (ru) | Дифференцирование человеческих эмбриональных стволовых клеток | |
BR112015019997A2 (pt) | Métodos de sacarificar e fermentar um material celulósico | |
WO2011082038A3 (en) | Improved reprogramming compositions | |
RU2011121843A (ru) | Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток | |
ATE492629T1 (de) | Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur | |
DE602006018768D1 (de) | Konditionell immortalisierte adulte langzeit-stammzellen und verfahren zur herstellung und verwendung von solchen zellen | |
MX2010001335A (es) | Diferenciacion de celulas madre embrionarias humanas. | |
MX2009002065A (es) | Una composicion farmaceutica para tratar cancer pulmonar, un metodo para inhibir el crecimiento o invasion de cancer pulmonar y un metodo para tratar cancer pulmonar. | |
MX2009004640A (es) | Estimulacion por litio de proliferacion de celula de tallo sanguinea de cordon y produccion de factor de crecimiento. | |
RU2014146170A (ru) | Способы лечения диабета и/или улучшения выживания панкреатических островков после трансплантации | |
TW200736399A (en) | Expansion and differentiation of neural stem cells under low oxygen conditions | |
ATE544849T1 (de) | Aktivierte dendritische zellen, therapieverfahren unter verwendung der dendritischen zellen sowie verfahren zur kultivierung von gamma-delta-t- zellen | |
EA201300817A1 (ru) | Способ улучшенного приживления гемопоэтических стволовых клеток | |
AR057058A1 (es) | Metodo para usar antagonistas de zonulina para prevenir la perdida o para regenerar celulas pancreaticas | |
MX2014001441A (es) | Metodo para aumentar la asimilación de dioxido de carbono (co2) y la producción de aceite en organismos fotosinteticos. | |
MX2011007936A (es) | Metodos para regeneracion de tejido pancreatico. | |
ATE519504T1 (de) | Chromatin-remodellierende substanzen zur erhöhung der expression von pdx-1 und förderung der zelldifferenzierung | |
ATE544846T1 (de) | Fusionierte mesenchymale stammzellen zur behandlung von diabetes und verfahren dafür | |
DK1554374T3 (da) | Fremgangsmåde til storskala T-lymfocytdyrkning i et homogent system | |
WO2014100816A3 (en) | Ghrh agonists for islet cell transplantation and function and the treatment of diabetes | |
RU2008106675A (ru) | Способ лечения периимплантита | |
ATE461994T1 (de) | Verfahren und vorrichtungen zum kultivieren von stammzellen | |
AR050723A1 (es) | Proceso para la preparacion de z-5- carboximetilen-1,3- dioxolan-4- onas |